217 related articles for article (PubMed ID: 12727837)
1. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines.
Montagna C; Lyu MS; Hunter K; Lukes L; Lowther W; Reppert T; Hissong B; Weaver Z; Ried T
Cancer Res; 2003 May; 63(9):2179-87. PubMed ID: 12727837
[TBL] [Abstract][Full Text] [Related]
2. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
[TBL] [Abstract][Full Text] [Related]
3. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
[TBL] [Abstract][Full Text] [Related]
4. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.
Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
[TBL] [Abstract][Full Text] [Related]
6. Interference of mouse polyomavirus with the c-myc gene and its product in mouse mammary adenocarcinomas.
Holländerová D; Raslová H; Blangy D; Forstová J; Berebbi M
Int J Oncol; 2003 Aug; 23(2):333-41. PubMed ID: 12851682
[TBL] [Abstract][Full Text] [Related]
7. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
[TBL] [Abstract][Full Text] [Related]
8. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Trimble MS; Xin JH; Guy CT; Muller WJ; Hassell JA
Oncogene; 1993 Nov; 8(11):3037-42. PubMed ID: 7692372
[TBL] [Abstract][Full Text] [Related]
9. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
11. Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors.
Kalikin LM; Sims HL; Petty EM
Genomics; 2000 Jan; 63(2):165-72. PubMed ID: 10673329
[TBL] [Abstract][Full Text] [Related]
12. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
Guy CT; Cardiff RD; Muller WJ
Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
[TBL] [Abstract][Full Text] [Related]
13. Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers.
Dong Y; Asch HL; Medina D; Ip C; Ip M; Guzman R; Asch BB
Int J Cancer; 1999 Jun; 81(6):930-8. PubMed ID: 10362141
[TBL] [Abstract][Full Text] [Related]
14. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
Hoenerhoff MJ; Shibata MA; Bode A; Green JE
Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
[TBL] [Abstract][Full Text] [Related]
15. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.
Jiang XP; Elliott RL; Head JF
Anticancer Res; 2010 Mar; 30(3):759-65. PubMed ID: 20392994
[TBL] [Abstract][Full Text] [Related]
17. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
18. Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions.
Marcus J; Bejerano-Sagie M; Patterson N; Bagchi S; Verkhusha VV; Connolly D; Goldberg GL; Golden A; Sharma VP; Condeelis J; Montagna C
Oncogene; 2019 Jul; 38(30):5839-5859. PubMed ID: 31285548
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.
Gonzalez ME; Makarova O; Peterson EA; Privette LM; Petty EM
Cell Signal; 2009 Apr; 21(4):477-87. PubMed ID: 19071215
[TBL] [Abstract][Full Text] [Related]
20. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
